Skip to Content

3138 WPI (Nizatidine 300 mg)

Pill with imprint 3138 WPI is Brown, Capsule-shape and has been identified as Nizatidine 300 mg. It is supplied by Watson Pharmaceuticals.

Nizatidine is used in the treatment of erosive esophagitis; gerd; duodenal ulcer; stomach ulcer; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 3138 WPI

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide